Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.
14 Analysts Have This to Say About McDonald’s
Analysts have provided the following ratings for McDonald's (NYSE:MCD) within the last quarter:
Jefferies Downgrades Applied Molecular to Hold
Jefferies analyst Chris Howerton downgrades Applied Molecular (NASDAQ:AMTI) from Buy to Hold.
Related Posts
Marathon Digital Pursuing Strategic Organization To Organize Itself Into Business Units Commencing During Q2 Of 2024
Strategic Organization of Business Units The Company is pursuing a strategic initiative to organize itself into business units commencing during the second quarter of 2024. The primary purpose of this initiative is
Beam Therapeutics’ Role In Gene-Editing 2.0 Revolution: First U.S. Patient Treated With Base-Edited Cell Therapy
Beam Therapeutics Inc (NASDAQ: BEAM) announced that in August, the first patient was treated with BEAM-201, a quadruplex-edited allogeneic
Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130
Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:META) with a Equal-Weight and raises the price target from $100 to $130.